Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doubletsDAE HO LEE; KIM, Sang-We; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 35-39, issn 0344-5704, 5 p.Article

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)RATHKOPF, Dana E; SMITH, Matthew R; BEER, Tomasz M et al.European urology. 2014, Vol 66, Num 5, pp 815-825, issn 0302-2838, 11 p.Article

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naive patients with malignant pleural mesothelioma : Outcomes of an expanded access programOBASAJ, Coleman K; ZHISHEN YE; WOZNIAK, Antoinette J et al.Lung cancer. 2007, Vol 55, Num 2, pp 187-194, issn 0169-5002, 8 p.Article

Multicenter Phase 2 Study of Belotecan, a New Camptothecin Analog, and Cisplatin for Chemotherapy-Naive Patients With Extensive-Disease Small Cell Lung CancerDAE HO LEE; KIM, Sang-We; SUNG HYUN YANG et al.Cancer. 2010, Vol 116, Num 1, pp 132-136, issn 0008-543X, 5 p.Article